Safety and efficacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial

被引:0
|
作者
Kebir, Sied [1 ]
Lazaridis, Lazaros [1 ]
Schmidt, Teresa [1 ]
Oster, Christoph [1 ]
Feldheim, Jonas [1 ]
Proescholdt, Martin [2 ]
Hau, Peter [2 ]
Grosu, Anca Ligia [3 ]
Krex, Dietmar [4 ]
Pierscianek, Daniela [5 ]
Sure, Ulrich [5 ]
Scheffler, Bjoern [6 ,7 ,8 ]
Kleinschnitz, Christoph [1 ]
Stuschke, Martin [9 ]
Glas, Martin [1 ]
机构
[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol,Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[2] Univ Med Ctr Regensburg, Dept Neurosurg, Regensburg, Germany
[3] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany
[5] Univ Hosp Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[6] Univ Med Essen, West German Canc Ctr WTZ, DKFZ Div Translat Neurooncol, Essen, Germany
[7] German Canc Consortium DKTK, Partner Site, Essen, Germany
[8] German Canc Res Ctr, Essen, Germany
[9] Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
VS09-1-jD
引用
收藏
页码:S32 / S32
页数:1
相关论文
共 50 条
  • [1] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Pierscianek, D.
    Guberina, N.
    Kleinschnitz, C.
    Proescholdt, M.
    Hau, P.
    Grosu, A. -L
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
  • [2] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Pierscianek, Daniela
    Guberina, Nika
    Kleinschnitz, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 61 - 61
  • [3] Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma-the PriCoTTF phase I/II trial
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Feldheim, J.
    Glas, M.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Scheffler, B.
    Kleinschnitz, C.
    Pottgen, C.
    Stuschke, M.
    NEURO-ONCOLOGY, 2022, 24
  • [4] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 68 - 68
  • [5] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, S.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 50 - 50
  • [6] INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Feldheim, Jonas
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Poettgen, Christoph
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2023, 25
  • [7] INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Feldheim, Jonas
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Poetgen, Christoph
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2022, 24 : 77 - 77
  • [8] PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, M.
    Scheffler, B.
    Lazaridis, L.
    Herrlinger, U.
    Pierscianek, D.
    Sure, U.
    Proescholdt, M.
    Hau, P.
    Hense, J.
    Kleinschnitz, C.
    Grosu, A.
    Stuschke, M.
    Kebir, S.
    NEURO-ONCOLOGY, 2018, 20 : 243 - 243
  • [9] PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Glas, Martin
    Scheffler, Bjoern
    Lazaridis, Lazaros
    Herrlinger, Ulrich
    Pierscianek, Daniela
    Sure, Ulrich
    Proescholdt, Martin
    Hau, Peter
    Hense, Joerg
    Kleinschnitz, Christoph
    Grosu, Anca-Ligia
    Stuschke, Martin
    Kebir, Sied
    NEURO-ONCOLOGY, 2018, 20 : 22 - 22
  • [10] Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF
    Kebir, Seid
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca L.
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Kleinschnitz, Christoph
    Ttgen, Christoph Po Spacing Diaeresis
    Stuschke, Martin
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)